Stockreport

AnaptysBio Announces First Quarter 2019 Financial Results and Provides Pipeline Updates

AnaptysBio, Inc.  (ANAB) 
Last anaptysbio, inc. earnings: 3/2 08:45 am Check Earnings Report
US:NASDAQ Investor Relations: ir.anaptysbio.com/investor-relations
PDF Multiple Top-line Phase 2 Clinical Efficacy Readouts from Wholly-owned Pipeline Anticipated in 2019Etokimab Phase 2a Severe Eosinophilic Asthma Data to be Presented at t [Read more]